No abstract available
MeSH terms
-
Clinical Protocols / standards
-
Clinical Trials, Phase II as Topic
-
Controlled Clinical Trials as Topic*
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Myocardial Infarction / drug therapy
-
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
-
Platelet Glycoprotein GPIIb-IIIa Complex / therapeutic use
-
Research Design / trends*
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Outcome
Substances
-
Fibrinolytic Agents
-
Platelet Glycoprotein GPIIb-IIIa Complex
-
Tissue Plasminogen Activator